234 related articles for article (PubMed ID: 26608620)
1. Development and characterisation of sustained release solid dispersion oral tablets containing the poorly water soluble drug disulfiram.
Shergill M; Patel M; Khan S; Bashir A; McConville C
Int J Pharm; 2016 Jan; 497(1-2):3-11. PubMed ID: 26608620
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterisation of Kolliphor® P 188 and P 237 solid dispersion oral tablets containing the poorly water soluble drug disulfiram.
Ramadhani N; Shabir M; McConville C
Int J Pharm; 2014 Nov; 475(1-2):514-22. PubMed ID: 25218186
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion.
Feng J; Xu L; Gao R; Luo Y; Tang X
Drug Dev Ind Pharm; 2012 Jun; 38(6):735-43. PubMed ID: 21999610
[TBL] [Abstract][Full Text] [Related]
4. Formulation of a poorly water-soluble drug in sustained-release hollow granules with a high viscosity water-soluble polymer using a fluidized bed rotor granulator.
Asada T; Yoshihara N; Ochiai Y; Kimura SI; Iwao Y; Itai S
Int J Pharm; 2018 Apr; 541(1-2):246-252. PubMed ID: 29496456
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water-soluble drug.
Tran HT; Park JB; Hong KH; Choi HG; Han HK; Lee J; Oh KT; Lee BJ
Int J Pharm; 2011 Aug; 415(1-2):83-8. PubMed ID: 21641985
[TBL] [Abstract][Full Text] [Related]
6. Formulating Amorphous Solid Dispersions: Impact of Inorganic Salts on Drug Release from Tablets Containing Itraconazole-HPMC Extrudate.
Takano R; Maurer R; Jacob L; Stowasser F; Stillhart C; Page S
Mol Pharm; 2020 Aug; 17(8):2768-2778. PubMed ID: 31794228
[TBL] [Abstract][Full Text] [Related]
7. Aqueous coating dispersion (pseudolatex) of zein improves formulation of sustained-release tablets containing very water-soluble drug.
Li XN; Guo HX; Heinamaki J
J Colloid Interface Sci; 2010 May; 345(1):46-53. PubMed ID: 20129615
[TBL] [Abstract][Full Text] [Related]
8. Physical properties and in vivo bioavailability in human volunteers of isradipine using controlled release matrix tablet containing self-emulsifying solid dispersion.
Tran PH; Tran TT; Piao ZZ; Vo TV; Park JB; Lim J; Oh KT; Rhee YS; Lee BJ
Int J Pharm; 2013 Jun; 450(1-2):79-86. PubMed ID: 23612354
[TBL] [Abstract][Full Text] [Related]
9. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
[TBL] [Abstract][Full Text] [Related]
10. A comparative study between melt granulation/compression and hot melt extrusion/injection molding for the manufacturing of oral sustained release thermoplastic polyurethane matrices.
Verstraete G; Mertens P; Grymonpré W; Van Bockstal PJ; De Beer T; Boone MN; Van Hoorebeke L; Remon JP; Vervaet C
Int J Pharm; 2016 Nov; 513(1-2):602-611. PubMed ID: 27686052
[TBL] [Abstract][Full Text] [Related]
11. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
Efentakis M; Naseef H; Vlachou M
Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
[TBL] [Abstract][Full Text] [Related]
12. The impact of the injection mold temperature upon polymer crystallization and resulting drug release from immediate and sustained release tablets.
Van Renterghem J; Dhondt H; Verstraete G; De Bruyne M; Vervaet C; De Beer T
Int J Pharm; 2018 Apr; 541(1-2):108-116. PubMed ID: 29409747
[TBL] [Abstract][Full Text] [Related]
13. Preparation and Characterization of pH-Independent Sustained-Release Tablets Containing Hot Melt Extruded Solid Dispersions of Clarithromycin : Tablets Containing Solid Dispersions of Clarithromycin.
Ijaz QA; Latif S; Shoaib QU; Rashid M; Arshad MS; Hussain A; Bukhari NI; Riaz S; Abbas N
AAPS PharmSciTech; 2021 Nov; 22(8):275. PubMed ID: 34773162
[TBL] [Abstract][Full Text] [Related]
14. Sustained-release amorphous solid dispersions.
Maincent J; Williams RO
Drug Deliv Transl Res; 2018 Dec; 8(6):1714-1725. PubMed ID: 29498004
[TBL] [Abstract][Full Text] [Related]
15. Investigation of Thermal and Viscoelastic Properties of Polymers Relevant to Hot Melt Extrusion, IV: Affinisol™ HPMC HME Polymers.
Gupta SS; Solanki N; Serajuddin AT
AAPS PharmSciTech; 2016 Feb; 17(1):148-57. PubMed ID: 26511936
[TBL] [Abstract][Full Text] [Related]
16. Perspectives on Strategies Using Swellable Polymers in Solid Dispersions for Controlled Drug Release.
Tran TTD; Tran PHL
Curr Pharm Des; 2017; 23(11):1639-1648. PubMed ID: 27774901
[TBL] [Abstract][Full Text] [Related]
17. Development of disulfiram-loaded poly(lactic-co-glycolic acid) wafers for the localised treatment of glioblastoma multiforme: a comparison of manufacturing techniques.
Zembko I; Ahmed I; Farooq A; Dail J; Tawari P; Wang W; Mcconville C
J Pharm Sci; 2015 Mar; 104(3):1076-86. PubMed ID: 25537972
[TBL] [Abstract][Full Text] [Related]
18. [Design of Novel Ophthalmic Formulation Containing Drug Nanoparticles and Its Usefulness as Anti-glaucoma Drugs].
Nagai N
Yakugaku Zasshi; 2016; 136(10):1385-1390. PubMed ID: 27725388
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of solid dispersion-microsphere controlled release system for poorly water-soluble drug.
Malipeddi VR; Dua K; Awasthi R
Drug Deliv Transl Res; 2016 Oct; 6(5):540-50. PubMed ID: 27343081
[TBL] [Abstract][Full Text] [Related]
20. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
